SALA LUCA

Hiniesto-Iñigo, I., Sridhar, A., Louradour, J., Cruz, A., Lundholm, S., Jauregi-Miguel, A., et al. (2025). Rescue of loss-of-function long QT syndrome-associated mutations in KV7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S). BRITISH JOURNAL OF PHARMACOLOGY, 182(13 (July 2025)), 2861-2877 [10.1111/bph.70008]. Detail

Sesti, V., Magni, A., Moschetta, M., Florindi, C., Pfeffer, M., Difrancesco, M., et al. (2025). Membrane-targeted push-pull azobenzenes for the optical modulation of membrane potential. LIGHT, SCIENCE & APPLICATIONS, 14(1) [10.1038/s41377-024-01669-x]. Detail

Clementi, T., Colonese, F., Canova, S., Abbate, M., Sala, L., Petrella, F., et al. (2025). Perioperative Chemo/Immunotherapies in Lung Cancer: A Critical Review on the Value of Perioperative Sequences. CURRENT ONCOLOGY, 32(7) [10.3390/curroncol32070397]. Detail

Florindi, C., Vurro, V., Ronchi, C., Sesti, V., Sala, L., Di Pasquale, E., et al. (2024). Geneless optomodulation of cardiomyocytes membrane potential by sarcolemma-targeted azobenzene photoswitches. In Abstracts of the XXIV Congress of the Italian Society of Cardiovascular Research (pp.1-12). ELSEVIER SCIENCE INC [10.1016/j.vph.2024.107317]. Detail

Sala, L., Khudiakov, A., Mura, M., Leonov, V., Giannetti, F., Crotti, L., et al. (2024). Use of hiPSC-derived cardiomyocytes to study LQTS-variant specific proarrhythmic effects of drugs. VASCULAR PHARMACOLOGY, 155(June 2024), 107347-107347 [10.1016/j.vph.2024.107347]. Detail